经济观察网 派格生物医药-B（02565.HK）股价于2月13日下跌5.54%，收报63.05港元。此次下跌主要受 市场整体走弱、纳入指数利好兑现、技术面承压、资金面分歧及高估值压力等多重因素影响。 从技术指标看，2月13日收盘价63.05港元低于5日均线（65.27港元）和20日均线（65.515港元），且 MACD柱状图虽转正但仍处于零轴下方，短期均线呈空头排列。当日振幅达9.51%，股价一度下探至 61.05港元，触及布林带下轨（58.974港元）附近，反映抛压较强。尽管当日资金整体净流入335.67万港 元，但主要为散户资金推动（净流入335.67万港元），主力资金净流入为0，显示机构观望情绪较浓。 换手率仅0.08%，成交额约1523万港元，流动性相对偏低，放大了个股波动。 公司最新估值 截至2月13日，公司市盈率（TTM）为-101.56倍，市净率达42.84倍，估值水平较高。根据2025年中期业 绩，公司研发开支为2629.4万元，持续投入压力较大。市场可能担忧其盈利前景与当前估值匹配度。 股票近期走势 2月13日，港股主要指数普遍下跌，恒生指数下跌1.72%，生物技术板块整体下跌0.95%。市 ...

Core Viewpoint - Xirui (02507) shares rose over 8%, reaching a new high of 69.45 HKD since August last year, with a trading volume of 54.2 million HKD [1] Group 1: Company Performance - Haitong International forecasts that Xirui will deliver approximately 800 aircraft in 2025, with around 600 new orders expected [1] - The company is expected to meet the requirements for market capitalization, trading volume, and turnover rate set by index companies by the end of 2025 [1] Group 2: Product Development - On February 3, Xirui launched the VisionJet G3, which features price increases and upgrades in intelligence and comfort [1] - West Securities believes that with the introduction of better-structured products like VisionJet G3 and SRG7+, the overall product structure will improve year-on-year, leading to enhanced profitability [1]

Core Viewpoint - Xirui (02507) shares rose over 8%, reaching a new high of 69.45 HKD since August last year, with a trading volume of 54.20 million HKD [1] Group 1: Company Performance - Haitong International forecasts that Xirui will deliver approximately 800 aircraft in 2025, with around 600 new orders expected [1] - The company is expected to meet the requirements for market capitalization, trading volume, and turnover rate set by index companies by the end of 2025 [1] Group 2: Product Development - On February 3, Xirui launched the VisionJet G3, which features price increases and upgrades in intelligence and comfort [1] - West Securities believes that with the introduction of better-structured products like VisionJet G3 and SRG7+, the overall product structure will improve year-on-year, enhancing profitability [1]

Core Viewpoint - Minglue Technology (2718.HK) debuted on the Hong Kong Stock Exchange with a closing increase of 106.1%, reaching a market capitalization of HKD 41.956 billion, indicating strong market demand with an oversubscription of 4452.86 times in the public offering and 13.93 times in the international offering [1] Group 1: Lock-up Periods for Shareholders - The cornerstone investors of Minglue Technology have a lock-up period of 270 days, which is 50% longer than the standard 180 days for cornerstone investors in Hong Kong, aimed at stabilizing stock prices before inclusion in the Stock Connect program [2] - The controlling shareholder has a lock-up period of 12 months, consistent with the standard rules for the main board in Hong Kong, which prohibits any share sales for the first 6 months and restricts sales in the following 6 months to maintain control [3][5] - Non-controlling shareholders have a lock-up period of 270 days, which is approximately 26% shorter than the customary 365 days, to balance liquidity and stability given the small float of the company [6][7] Group 2: Special Arrangements - The extended lock-up for cornerstone investors is designed to prevent share sales that could negatively impact stock prices during a critical period before the company qualifies for Stock Connect [2] - The controlling shareholder's additional commitment to a 12-month lock-up for B shares is an extra constraint rather than a regulatory requirement, maintaining alignment with standard practices [5] - The overall lock-up arrangements reflect a targeted adjustment strategy, extending the lock-up for cornerstone investors while aligning other shareholders with standard practices or shortening their periods to ensure liquidity [8]

Core Viewpoint - The report from GF Securities highlights the significant stock price increase of Horizon Robotics (09660) by 11.4% after being included in the Hong Kong Stock Connect, suggesting a potential timing opportunity based on capital flow [1] Group 1: Market Behavior Post Inclusion - After being included in the Stock Connect, leading companies often experience immediate capital inflow, resulting in stock price increases, with the steepest inflow observed in the initial days [2] - However, the short-term price increase is not universally applicable to all companies, indicating that this is not a straightforward quantitative timing strategy [2] - This strategy is more effective for high-quality leading companies that have been thoroughly researched and recognized by active funds, which are likely to buy quickly after inclusion [2] Group 2: Future Inclusion Candidates - There are two fixed "inclusion" periods each year: the first week of March and September, with the next inclusion effective the following Monday, primarily based on the company's inclusion in the Hang Seng Composite Index [3] - Additionally, there are quarterly rapid inclusions for newly listed companies, which are subject to specific criteria such as average market capitalization [3][4] - Potential companies for future inclusion include: - June 6: Bruker, Mixue Group, and Gu Ming [5][6] - Late June: CATL and Hengrui Medicine [5][6] - September 5: Companies like Conant Optical and others [5][6]